Cargando…
Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
BACKGROUND: Fibroblast growth factor-23 (FGF-23), a novel marker of bone disease in chronic kidney disease (CKD) has been shown to correlate with vascular calcifications. We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults wit...
Autores principales: | Yasin, Abeer, Liu, Daisy, Chau, Luan, Madrenas, Joaquín, Filler, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598245/ https://www.ncbi.nlm.nih.gov/pubmed/23413976 http://dx.doi.org/10.1186/1471-2369-14-39 |
Ejemplares similares
-
Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021) -
Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018) -
The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women
por: Holecki, M., et al.
Publicado: (2011) -
Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009) -
Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor
por: Chau, Luan A., et al.
Publicado: (1998)